In Part I of this article, we talked about the potential risks of SSRIs during pregnancy, as well as the risks of untreated depression and other mental health issues. Cliquez ici to find out what the research shows, and why the calculus behind remaining on an SSRI during pregnancy is a nuanced decision.
Now, in Part II, we’ll dive into what your options are if you’re considering pregnancy or are already pregnant and on an SSRI.
Honestly evaluate if remaining on an SSRI is the safest option—for you, and your baby
There are certainly situations when staying on an SSRI during pregnancy is likely the safest option for you and your baby. If you have severe depression with suicidal ideation, history of multiple severe relapses after going off SSRIs, psychotic symptoms or complete loss of functioning, previous psychiatric hospitalization, or failed attempts at non-pharmological treatment, SSRIs during pregnancy may be literally life-saving for the both of you. And, as we discussed in Part I, evidence is conflicting around whether SSRI exposure truly poses measurable harm to a developing baby.
Given the uncertainty, however, some women (especially those with “milder” conditions than those listed above) may want to know what other options exist for managing mental health during pregnancy. In this article, we’ll look at tapering off medication, what withdrawal looks like, and alternatives to SSRIs.
As always, nothing in this article should be construed as medical advice, or as fear-mongering around SSRIs and other mental health therapies. Our goal at Natural Womanhood is to present women with the best information possible, so they can make empowered, informed decisions about their own health and pregnancies.
The tapering timeline you might not know about
Before pregnancy
If you’re a safe candidate for attempting to discontinue antidepressant use, here’s what your doctor might tell you: “You can taper off over 2-4 weeks.” Here’s what the research actually shows, however: most people require 6-12 months or longer to completely discontinue SSRIs using gradual methods. That extended timeline typically results in more tolerable symptoms and higher success rates, but it means that if you think you might want to be antidepressant-free while pregnant, you need to start planning well avant you start trying to conceive.
Most people require 6-12 months or longer to completely discontinue SSRIs using gradual methods. That extended timeline typically results in more tolerable symptoms and higher success rates, but it means that if you think you might want to be antidepressant-free while pregnant, you need to start planning well avant you start trying to conceive.
Safe tapering requires:
- Medical supervision by a medical professional experienced in antidepressant discontinuation (and not all psychiatrists specialize in this)
- “Hyperbolic” dose reductions (proportional decreases) rather than linear cuts
- Accounting for the medication’s half-life. Paroxetine and venlafaxine are particularly difficult to discontinue
- Adjustment based on individual response
- Monitoring to distinguish withdrawal from relapse
If you’re already pregnant
If you’re already pregnant and want to taper off your SSRI, you still need to do so gradually and under medical guidance. Abrupt discontinuation risks severe withdrawal and relapse.
Starting earlier in pregnancy may be best: research suggère that tapering SSRIs in late pregnancy doesn’t reduce neonatal adaptation syndrome, and may increase maternal relapse risk. Many experts recommend continuing at your effective dose through delivery rather than tapering at this stage.
SSRI withdrawal vs. depression relapse
Whether you’re already pregnant or considering pregnancy and want to begin tapering off your SSRI, the distinction between SSRI withdrawal symptoms and true depression relapse is important to understand. Some women may unnecessarily restart medication because they mistake withdrawal for the return of depression.
Withdrawal symptoms typically emerge within days of dose reduction and include:
- “Brain zaps” or electric shock sensations (distinctive to withdrawal)
- Dizziness and vertigo
- Flu-like symptoms
- Sensory disturbances
- Rapid onset right after dose change
Depression relapse typically develops more gradually:
- Persistent low mood
- Loss of interest in activities
- Changes in sleep and appetite
- Negative thought patterns
- Gradual worsening over weeks
Having a healthcare professional guide you through the SSRI tapering process who understands this distinction isn’t just helpful—it’s essential.
Non-pharmaceutical options for improving mental health
For women seeking alternatives or additions to medication, the following is a list of what the evidence supports—and each offers benefits for women who are already pregnant, as well as women who are considering pregnancy.
Psychothérapie
Cognitive-behavioral therapy (CBT) and interpersonal therapy (IPT) have shown effectiveness for perinatal depression comparable to medication in some studies [2]. In the UK and Canada, these are considered first-line treatments. The catch? Access can be challenging, wait times are long, and these work best for mild to moderate depression rather than severe cases. But if you have access to quality therapy, it’s worth prioritizing.
La nutrition
Omega-3 fatty acids (EPA and DHA), vitamine D, B vitamins, and magnésium have been étudié for mood support during pregnancy [2]. The research quality is mixed, and effects are generally modest compared to medication or therapy. But each of these supplements is a low-risk addition that may help, especially for mild symptoms.
Movement and light
Regular physical activity and natural sunlight can support mood naturally [3]. Exercise has demonstrated antidepressant effects and may help prevent relapse during medication tapering. Neither physical activity nor sunlight are a cure-all, but both are accessible and beneficial for other pregnancy outcomeségalement.
Addressing root causes
Pour certaines femmes, problèmes de thyroïde, faible taux de progestéroneou blood sugar imbalances contribute to mood symptoms. These are worth evaluating, though they represent specific medical conditions rather than alternatives to treating clinical depression.
Community, purpose, and connection
Here’s something we don’t talk about enough: isolation worsens mental health, while belonging and community strengthen resilience. Social connection, spiritual practices, and finding purpose can provide support that addresses dimensions of wellbeing beyond biology. Like everything else listed above, these aren’t replacements for treatment when you need it, but they’re powerful additions.
The bottom line on SSRIs in pregnancy: Informed consent and patient’s choices matter
In Dr. Urato’s statement to the FDA (discussed in Part I), he mentioned that “A big part of compassionate care is giving patients the proper information about risks and benefits of treatment, and then supporting their choices.” He notes, “over the years I’ve seen more and more medication use in pregnancy, and I think that pregnant women and the public aren’t being properly informed on this issue, particularly with SSRI antidepressants.”
Every woman deserves the full picture before making decisions that could affect her health and her baby’s development. That means acknowledging the following:
- No medication is without risk, and the evidence on SSRIs shows both potential risks and significant uncertainties
- The absolute risks of most adverse outcomes remain relatively small (understanding the difference between “doubled risk” and actual risk matters enormously)
- Untreated maternal depression also carries significant, measurable risks
- Stopping SSRIs suddenly can be genuinely dangerous, and proper tapering takes time
- The decision to begin or discontinue SSRI treatment depends on your specific situation: depression severity, treatment history, support systems, and personal risk tolerance
A frank discussion around the nuances of SSRI treatment during pregnancy doesn’t deny that these medications can sometimes be helpful—or even necessary. Rather, it seeks to promote fuller transparency about what we know and don’t know about their use in pregnancy. It likewise points out that the current gaps in research serve no one—whether it’s women, their doctors, or their babies. Women deserve access to this information, as well as access to both pharmaceutical and non-pharmaceutical approaches, supported by honest information about risks, benefits, and uncertainties.
A frank discussion around the nuances of SSRI treatment during pregnancy doesn’t deny that these medications can sometimes be helpful—or even necessary. Rather, it seeks to promote fuller transparency about what we know and don’t know about their use in pregnancy. It likewise points out that the current gaps in research serve no one—whether it’s women, their doctors, or their babies.
When women are trusted with complete information and supported with comprehensive care options, they can make informed decisions that honor both their mental health needs and their baby’s development. This is what truly ethical and holistic pregnancy care looks like.
